NASDAQ : EYPT
EyePoint, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.38 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 32.76M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
EyePoint, Inc. (EYPT) reported revenue of 2.79M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 2.79M | 31.37M | 43.27M | 46.02M | 41.40M | 36.94M |
| Cost of Revenue | 260.26M | 219.11M | 133.90M | 68.13M | 57.97M | 36.07M |
| Gross Profit | -257.47M | -187.74M | -90.63M | -22.11M | -16.56M | 868.00K |
| Selling, General & Admin | 59.50M | 55.69M | 55.23M | 52.95M | 60.32M | 53.68M |
| Amortization of Goodwill & Intangibles | 2.05M | 2.46M | ||||
| Operating Expenses | 59.50M | 55.69M | 55.23M | 52.95M | 62.37M | 56.14M |
| Operating Income | -316.98M | -243.43M | -145.85M | -75.07M | -78.94M | -55.28M |
| Interest Expense | -33.00K | -33.00K | -14.00K | -1.25M | -3.19M | -5.50M |
| Interest & Investment Income | 10.50M | 11.78M | 15.09M | 6.95M | 2.13M | 292.00K |
| EBT Excluding Unusual Items | -306.51M | -231.68M | -130.78M | -69.36M | -80.00M | -60.48M |
| Asset Writedown | -20.70M | |||||
| Other Unusual Items | -1.35M | -1.56M | 2.06M | |||
| Pretax Income | -306.51M | -231.68M | -130.78M | -70.71M | -102.25M | -58.42M |
| Income Tax Expense | 136.00K | 279.00K | 90.00K | 83.00K | ||
| Net Income | -306.64M | -231.96M | -130.87M | -70.80M | -102.25M | -58.42M |
| Net Income to Common | -306.64M | -231.96M | -130.87M | -70.80M | -102.25M | -58.42M |
| Shares Outstanding (Basic) | 81.46M | 73.25M | 56.30M | 38.90M | 37.32M | 28.76M |
| Shares Outstanding (Diluted) | 81.46M | 73.25M | 56.30M | 38.90M | 37.32M | 28.76M |
| EPS (Basic) | -3.76 | -3.17 | -2.32 | -1.82 | -2.74 | -2.03 |
| EPS (Diluted) | -3.76 | -3.17 | -2.32 | -1.82 | -2.74 | -2.03 |
| Free Cash Flow | -271.28M | -243.39M | -130.28M | -1.61M | -67.16M | -50.25M |
| Free Cash Flow Per Share | -3.33 | -3.32 | -2.31 | -0.04 | -1.80 | -1.75 |
| Gross Margin | -209.43% | -48.05% | -40.01% | 2.35% | ||
| Operating Margin | -11,369.30% | -775.98% | -337.06% | -163.12% | -190.65% | -149.64% |
| Profit Margin | -10,998.67% | -739.41% | -302.43% | -153.84% | -246.97% | -158.15% |
| Free Cash Flow Margin | -9,730.24% | -775.84% | -301.06% | -3.49% | -162.19% | -136.04% |
| EBITDA | -314.38M | -241.12M | -144.31M | -74.60M | -76.49M | -52.51M |
| EBITDA Margin | -162.12% | -184.75% | -142.14% | |||
| D&A For EBITDA | 2.60M | 2.31M | 1.54M | 464.00K | 2.45M | 2.77M |
| EBIT | -316.98M | -243.43M | -145.85M | -75.07M | -78.94M | -55.28M |
| EBIT Margin | -163.12% | -190.65% | -149.64% | |||
| Revenue as Reported | 2.79M | 31.37M | 43.27M | 46.02M | 41.40M | 36.94M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 110.46M | 101.82M | 99.70M | 281.26M | 95.63M | 178.59M |
| Short-Term Investments | 70.01M | 204.26M | 271.21M | 49.79M | 48.93M | 32.97M |
| Cash & Short-Term Investments | 180.47M | 306.09M | 370.91M | 331.05M | 144.56M | 211.56M |
| Receivables | 86.00K | 651.00K | 607.00K | 805.00K | 15.50M | 18.35M |
| Inventory | 1.88M | 1.81M | 2.31M | 3.91M | 2.89M | 3.62M |
| Prepaid Expenses | 5.39M | 18.14M | 8.08M | 8.03M | 9.08M | 4.22M |
| Other Current Assets | 987.00K | 1.96M | 1.41M | 1.01M | 782.00K | |
| Total Current Assets | 188.82M | 328.65M | 383.31M | 344.80M | 172.81M | 237.75M |
| Property, Plant & Equipment | 29.86M | 29.25M | 29.18M | 10.23M | 7.40M | 2.73M |
| Other Intangible Assets | 22.75M | |||||
| Other Long-Term Assets | 9.52M | 6.09M | 5.98M | 150.00K | 150.00K | 150.00K |
| Total Assets | 228.19M | 364.00M | 418.46M | 355.18M | 180.36M | 263.37M |
| Accounts Payable | 17.27M | 10.49M | 11.72M | 6.50M | 5.92M | 7.38M |
| Accrued Expenses | 21.94M | 24.33M | 17.96M | 16.76M | 15.34M | 11.45M |
| Short-Term Debt | 10.47M | |||||
| Current Portion of Leases | 2.55M | 2.02M | 1.25M | 563.00K | 543.00K | 782.00K |
| Current Unearned Revenue | 17.78M | 38.59M | 1.21M | 1.07M | ||
| Other Current Liabilities | 187.00K | 180.00K | 340.00K | 843.00K | 1.05M | 2.97M |
| Total Current Liabilities | 41.94M | 37.02M | 49.05M | 63.26M | 34.54M | 23.66M |
| Long-Term Debt | 29.31M | 36.56M | ||||
| Long-Term Leases | 19.81M | 20.77M | 21.86M | 4.91M | 5.98M | 1.90M |
| Long-Term Unearned Revenue | 10.85M | 20.69M | 13.56M | 14.56M | ||
| Other Long-Term Liabilities | 23.00K | 87.00K | 205.00K | 600.00K | 2.32M | |
| Total Liabilities | 61.78M | 57.88M | 81.96M | 88.86M | 83.99M | 78.99M |
| Common Stock | 85.00K | 83.00K | 68.00K | 49.00K | 34.00K | 34.00K |
| Additional Paid-In Capital | 1.45B | 1.41B | 1.21B | 1.01B | 766.90M | 752.60M |
| Retained Earnings | -1.28B | -1.10B | -873.02M | -742.15M | -671.35M | -569.10M |
| Comprehensive Income & Other | 793.00K | 961.00K | 1.03M | 864.00K | 786.00K | 841.00K |
| Shareholders' Equity | 166.41M | 306.11M | 336.50M | 266.32M | 96.37M | 184.38M |
| Total Liabilities & Equity | 228.19M | 364.00M | 418.46M | 355.18M | 180.36M | 263.37M |
| Total Debt | 22.37M | 22.79M | 23.11M | 5.47M | 46.31M | 39.24M |
| Net Cash (Debt) | 158.10M | 283.29M | 347.81M | 325.58M | 98.25M | 172.32M |
| Net Cash Per Share | 1.94 | 3.87 | 6.18 | 8.37 | 2.63 | 5.99 |
| Filing Date Shares Outstanding | 86.21M | 83.43M | 68.73M | 49.83M | 34.30M | 34.04M |
| Total Common Shares Outstanding | 84.98M | 82.83M | 68.27M | 49.04M | 34.08M | 33.91M |
| Working Capital | 146.87M | 291.63M | 334.26M | 281.54M | 138.27M | 214.09M |
| Book Value Per Share | 1.96 | 3.70 | 4.93 | 5.43 | 2.83 | 5.44 |
| Tangible Book Value | 166.41M | 306.11M | 336.50M | 266.32M | 96.37M | 161.63M |
| Tangible Book Value Per Share | 1.96 | 3.70 | 4.93 | 5.43 | 2.83 | 4.77 |
| Construction In Progress | 1.46M | 1.51M | 3.73M | |||
| Leasehold Improvements | 4.18M | 4.13M | 1.01M | 1.01M | 255.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -306.64M | -231.96M | -130.87M | -70.80M | -102.25M | -58.42M |
| Depreciation & Amortization | 2.60M | 2.31M | 1.54M | 464.00K | 2.45M | 2.77M |
| Asset Writedown & Restructuring Costs | 20.70M | |||||
| Loss (Gain) From Sale of Investments | -1.30M | |||||
| Stock-Based Compensation | 35.21M | 27.87M | 36.74M | 12.06M | 14.18M | 7.45M |
| Other Operating Activities | -2.49M | -4.55M | -5.86M | 1.27M | 2.95M | -159.00K |
| Change in Accounts Receivable | 377.00K | -10.67M | -244.00K | 14.43M | -2.66M | -10.60M |
| Change in Inventory | 796.00K | 492.00K | 1.60M | -1.55M | -760.00K | 1.35M |
| Change in Accounts Payable | 7.73M | 4.68M | 5.73M | 1.52M | 1.20M | 8.48M |
| Change in Unearned Revenue | -28.64M | -30.65M | 44.52M | -868.00K | -931.00K | |
| Change in Other Net Operating Assets | -3.58M | 354.00K | -4.21M | -39.00K | 69.00K | -28.00K |
| Operating Cash Flow | -267.30M | -240.11M | -126.23M | 1.88M | -65.00M | -50.10M |
| Capital Expenditures | -3.98M | -3.28M | -4.05M | -3.48M | -2.15M | -156.00K |
| Sale of Property, Plant & Equipment | 155.00K | 155.00K | ||||
| Investment in Securities | 118.70M | 71.70M | -215.30M | 168.00K | -15.12M | -32.97M |
| Investing Cash Flow | 114.88M | 68.58M | -219.35M | -3.31M | -17.27M | -33.12M |
| Short-Term Debt Issued | 5.30M | 43.88M | ||||
| Long-Term Debt Issued | 30.00M | |||||
| Total Debt Issued | 5.30M | 73.88M | ||||
| Short-Term Debt Repaid | -15.78M | -33.40M | ||||
| Long-Term Debt Repaid | -105.00K | -105.00K | -30.04M | -38.37M | -146.00K | |
| Total Debt Repaid | -111.00K | -105.00K | -105.00K | -45.81M | -71.77M | -146.00K |
| Net Debt Issued (Repaid) | -111.00K | -105.00K | -105.00K | -40.51M | 2.10M | -146.00K |
| Issuance of Common Stock | 196.12M | 175.68M | 169.31M | 229.55M | 395.00K | 217.20M |
| Repurchase of Common Stock | -3.63M | -1.39M | -4.51M | -169.00K | -295.00K | -150.00K |
| Other Financing Activities | -641.00K | -543.00K | -672.00K | -1.80M | -2.89M | |
| Financing Cash Flow | 191.74M | 173.65M | 164.02M | 187.07M | -690.00K | 216.90M |
| Net Cash Flow | 39.31M | 2.12M | -181.56M | 185.63M | -82.96M | 133.68M |
| Free Cash Flow | -271.28M | -243.39M | -130.28M | -1.61M | -67.16M | -50.25M |
| Free Cash Flow Margin | -9,730.24% | -775.84% | -301.06% | -3.49% | -162.19% | -136.04% |
| Free Cash Flow Per Share | -3.33 | -3.32 | -2.31 | -0.04 | -1.80 | -1.75 |
| Levered Free Cash Flow | -155.01M | -148.24M | -70.48M | 15.02M | -38.27M | -27.22M |
| Unlevered Free Cash Flow | -154.99M | -148.22M | -70.47M | 15.80M | -36.28M | -23.79M |
| Cash Interest Paid | 1.41M | 2.60M | 4.85M | |||
| Change in Working Capital | 5.33M | -33.78M | -27.77M | 58.88M | -3.02M | -1.74M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 30.04M | 1.51B | 522.69M | 1.09B | 119.29M | 414.86M |
| Enterprise Value | -128.07M | 1.33B | 292.01M | 958.11M | 8.49M | 334.43M |
| Last Close Price | 0.35 | 18.27 | 7.45 | 23.11 | 3.50 | 12.24 |
| Forward PE | 39.30 | 39.30 | 39.30 | 39.30 | 39.30 | |
| PS Ratio | 10.77 | 48.21 | 12.08 | 23.64 | 2.88 | 11.23 |
| PB Ratio | 0.18 | 4.94 | 1.55 | 4.08 | 1.24 | 2.25 |
| P/TBV Ratio | 0.18 | 4.94 | 1.55 | 4.08 | 1.24 | 2.57 |
| P/OCF Ratio | 580.20 | |||||
| EV/Sales Ratio | 42.45 | 6.75 | 20.82 | 0.20 | 9.05 | |
| Debt / Equity Ratio | 0.13 | 0.07 | 0.07 | 0.02 | 0.48 | 0.21 |
| Net Debt / Equity Ratio | -0.95 | -0.93 | -1.03 | -1.22 | -1.02 | -0.94 |
| Net Debt / EBITDA Ratio | 0.50 | 1.18 | 2.41 | 4.36 | 1.28 | 3.28 |
| Net Debt / FCF Ratio | 0.58 | 1.16 | 2.67 | 202.48 | 1.46 | 3.43 |
| Asset Turnover | 0.01 | 0.08 | 0.11 | 0.17 | 0.19 | 0.21 |
| Inventory Turnover | 114.15 | 106.42 | 43.12 | 20.06 | 17.83 | 8.06 |
| Quick Ratio | 4.30 | 8.29 | 7.58 | 5.25 | 4.63 | 9.72 |
| Current Ratio | 4.50 | 8.88 | 7.82 | 5.45 | 5.00 | 10.05 |
| Return on Equity (ROE) | -148.70% | -72.19% | -43.42% | -39.04% | -72.84% | -57.58% |
| Return on Assets (ROA) | -74.85% | -38.89% | -23.57% | -17.52% | -22.24% | -19.46% |
| Return on Capital Employed (ROCE) | -170.20% | -74.50% | -39.50% | -25.70% | -54.10% | -23.10% |
| Earnings Yield | -1,080.42% | -15.34% | -25.04% | -6.51% | -85.72% | -14.08% |
| FCF Yield | -903.17% | -16.09% | -24.92% | -0.15% | -56.29% | -12.11% |
| Buyback Yield / Dilution | -25.92% | -30.11% | -44.71% | -4.25% | -29.76% | -124.04% |